[go: up one dir, main page]

GB201914640D0 - Novel compounds and their use in therapy - Google Patents

Novel compounds and their use in therapy

Info

Publication number
GB201914640D0
GB201914640D0 GB201914640A GB201914640A GB201914640D0 GB 201914640 D0 GB201914640 D0 GB 201914640D0 GB 201914640 A GB201914640 A GB 201914640A GB 201914640 A GB201914640 A GB 201914640A GB 201914640 D0 GB201914640 D0 GB 201914640D0
Authority
GB
United Kingdom
Prior art keywords
therapy
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201914640A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Of Kent, University of
University of Kent at Canterbury
Rothamsted Research Ltd
Original Assignee
Of Kent, University of
University of Kent at Canterbury
Rothamsted Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Of Kent, University of, University of Kent at Canterbury, Rothamsted Research Ltd filed Critical Of Kent, University of
Priority to GB201914640A priority Critical patent/GB201914640D0/en
Publication of GB201914640D0 publication Critical patent/GB201914640D0/en
Priority to US17/426,424 priority patent/US20220105113A1/en
Priority to PCT/GB2020/050203 priority patent/WO2020157494A1/en
Priority to EP20705782.9A priority patent/EP3917940A1/en
Priority to CN202080025334.8A priority patent/CN113710681A/en
Priority to GB2001209.2A priority patent/GB2581035B/en
Ceased legal-status Critical Current

Links

GB201914640A 2019-01-30 2019-10-10 Novel compounds and their use in therapy Ceased GB201914640D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB201914640A GB201914640D0 (en) 2019-10-10 2019-10-10 Novel compounds and their use in therapy
US17/426,424 US20220105113A1 (en) 2019-01-30 2020-01-29 Cylodimer of dehydrosalicortin and derivatives thereof isolated from plant of the genus salix for use in cancer therapy
PCT/GB2020/050203 WO2020157494A1 (en) 2019-01-30 2020-01-29 Cylodimer of dehydrosalicortin and derivatives thereof isolated from plant of the genus salix for use in cancer therapy
EP20705782.9A EP3917940A1 (en) 2019-01-30 2020-01-29 Cylodimer of dehydrosalicortin and derivatives thereof isolated from plant of the genus salix for use in cancer therapy
CN202080025334.8A CN113710681A (en) 2019-01-30 2020-01-29 Dehydroepiloside cyclic dimers and derivatives thereof isolated from Salix species for cancer therapy
GB2001209.2A GB2581035B (en) 2019-01-30 2020-01-29 Novel compounds and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201914640A GB201914640D0 (en) 2019-10-10 2019-10-10 Novel compounds and their use in therapy

Publications (1)

Publication Number Publication Date
GB201914640D0 true GB201914640D0 (en) 2019-11-27

Family

ID=68619624

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201914640A Ceased GB201914640D0 (en) 2019-01-30 2019-10-10 Novel compounds and their use in therapy

Country Status (1)

Country Link
GB (1) GB201914640D0 (en)

Similar Documents

Publication Publication Date Title
IL284053A (en) Novel compounds and their use in therapy
EP3250609A4 (en) Il13ra alpha 2 binding agents and use thereof in cancer treatment
GB201511382D0 (en) Novel compounds and their use in therapy
GB201905520D0 (en) Compounds and their therapeutic use
SG11202110480YA (en) Imidazolonylquinoline compounds and therapeutic uses thereof
GB201715194D0 (en) Compounds and their therapeutic use
GB201813312D0 (en) Compounds and their therapeutic use
IL288728A (en) Anti-sortilin antibodies for use in therapy
GB202019475D0 (en) Therapeutic compounds and their use
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
GB202014736D0 (en) Novel compounds and their use in therapy
GB202108572D0 (en) Therapeutic compounds and their use
GB201918541D0 (en) Therapeutic compounds and their use
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
ZA201905402B (en) Compounds and their use in the treatment of schistosomiasis
IL284981A (en) Semaphorin-4d antagonists for use in cancer therapy
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
PL3325478T3 (en) New therapeutic compound and use in therapy
SG11202105276TA (en) Oligo-benzamide analogs and their use in cancer treatment
IL280555A (en) Substituted benzamides and their use in therapy
GB2581035B (en) Novel compounds and their use in therapy
GB2609814B (en) Terpenophenolic compounds and their use
GB201914640D0 (en) Novel compounds and their use in therapy
GB201913448D0 (en) Novel compounds and their use in therapy
GB201913450D0 (en) Novel compounds and their use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)